Bengaluru: On the occasion of Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries, has introduced the StrandOmics Portal, an online platform aimed at enhancing the diagnosis of rare diseases.
The portal provides clinicians with access to genetic variant information, offering a comprehensive case view to facilitate faster and more accurate diagnoses. To further support patients, Strand Life Sciences has announced subsidized genetic testing for individuals from economically disadvantaged backgrounds.
The StrandOmics Portal is designed to assist doctors by offering deeper genetic insights, enabling an independent review of a broader range of genetic variants, and enhancing prenatal diagnosis through improved collaboration among specialists.
Dr. Ramesh Hariharan, CEO & Co-Founder, Strand Life Sciences, informed that they will continue to innovate and invest in tools like the StrandOmics Portal to empower doctors in their fight against rare diseases.
